speb/financial-data huggingface dataset:
Financial ratios for ERD.TO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -855895.6204379562
Net income: -3008999.9999999995
Capital expenditures: 193275.91240875912
Operating cash flow: -860232.8467153284
Depreciation & amortization: 3654.744525547445
Net tangible assets: 40327555.474452555
Owner earnings: -3198621.167883211
Return on net tangible assets (%): -7.931601928883422
Buffett classification: The Gruesome
Stock price: 3.8540145985401457
Shares outstanding: 65493042
Book value: 40327555.47445255
P/B ratio: 6.259024059385524
Market cap (USD): 252411139.9708029
Debt to equity: 0.0018176157502637483
Current ratio: 5.668945778621655
Quick ratio: 5.668945778621655
Interest coverage ratio: -1621.8215767634856
Free cash flow (dilution-adjusted): -1293618.2481751824
Buyback yield (%): 0
Retained earnings: -106114568.61313868
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.119417817799479
Rule of 40 score: 0
Financial ratios for ERD.TO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -989010.9489051094
Net income: 2328597.8102189777
Capital expenditures: 1104959.8540145985
Operating cash flow: -744559.1240875912
Depreciation & amortization: 6793.430656934306
Net tangible assets: 39805418.24817518
Owner earnings: 1230431.3868613134
Return on net tangible assets (%): 3.0911153330683083
Buffett classification: The Gruesome
Stock price: 6.021897810218977
P/E ratio: 42.34226327895707
Shares outstanding: 65493042
Book value: 39805418.24817518
P/B ratio: 9.908008094412118
Market cap (USD): 394392406.2043795
Debt to equity: 0.0016289643142334928
Current ratio: 3.535534998693266
Quick ratio: 3.535534998693266
Interest coverage ratio: -703.8675324675326
Free cash flow (dilution-adjusted): -1909908.0291970803
Buyback yield (%): 0
Retained earnings: -105792416.05839415
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.481703289027728
Rule of 40 score: 0
Financial ratios for ERD.TO — annual report dated 2025-12-31
Total revenue: 0
Operating income: -4705249.635036496
Net income: -5972147.445255474
Capital expenditures: 1094140.1459854015
Operating cash flow: -3377249.635036496
Depreciation & amortization: 19111.678832116788
Net tangible assets: 39805418.24817518
Owner earnings: -7047175.912408759
Return on net tangible assets (%): -17.704061965814983
Buffett classification: The Gruesome
Stock price: 6.021897810218977
Shares outstanding: 65493042
Book value: 39805418.24817518
P/B ratio: 9.908008094412118
Market cap (USD): 394392406.2043795
Debt to equity: 0.0016289643142334928
Current ratio: 3.535534998693266
Quick ratio: 3.535534998693266
Interest coverage ratio: -1366.8770144189994
Free cash flow (dilution-adjusted): -5668354.014598539
Buyback yield (%): 0
Retained earnings: -105792416.05839415
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.806778790359926
Rule of 40 score: 0
Financial ratios for ETOR — quarterly report dated 2025-06-30
Total revenue: 615576401.1799409
Gross profit: 61862831.85840708
Operating income: 12393510.324483775
Net income: 8904129.793510323
Capital expenditures: 223893.8053097345
Operating cash flow: 17978171.091445427
Depreciation & amortization: 881415.9292035397
Net tangible assets: 375701474.9262537
Owner earnings: 9561651.917404128
Return on net tangible assets (%): 2.5450131435552605
Capex to operating income (%): 1.8065406769172183
Buffett classification: The Great
Stock price: 66.59
P/E ratio: 176.87574570817907
Shares outstanding: 66806610
Book value: 388991445.4277286
P/B ratio: 11.436375303853625
Market cap (USD): 4448652159.900001
Debt to equity: 0.038863076058576716
Current ratio: 4.453102303665207
Quick ratio: 4.453102303665207
Effective tax rate (%): 15.255902748533085
Interest coverage ratio: 3.0387675394184868
COGS to revenue (%): 89.95042179332607
R&D to revenue (%): 1.8618423196428608
SG&A to revenue (%): 6.174417913709195
Free cash flow (dilution-adjusted): 16609439.528023599
Buyback yield (%): 0
Retained earnings: 12592920.3539823
Receivables turnover: 28.757720664232064
Capitalized R&D asset: 18110403.41031729
ROCI (R&D-adjusted, %): 3.9257918386092454
Rosenberg metric: 0.1613787050468889
FCF margin (%): 2.6981930262736706
Revenue growth (%): -39.44693361237214
Rule of 40 score: -36.74874058609847
Financial ratios for ETOR — quarterly report dated 2025-09-30
Total revenue: 1239916918.429003
Gross profit: 64948338.36858006
Operating income: 21673111.78247734
Net income: 17165256.79758308
Capital expenditures: 539274.924471299
Operating cash flow: 12662537.764350453
Depreciation & amortization: 952567.9758308157
Net tangible assets: 402896374.6223565
Owner earnings: 17578549.848942596
Return on net tangible assets (%): 4.363044930701934
Capex to operating income (%): 2.488221026513145
Buffett classification: The Great
Stock price: 41.27
P/E ratio: 65.15439885832944
Shares outstanding: 66806610
Book value: 416316616.3141994
P/B ratio: 6.62262491252373
Market cap (USD): 2757108794.7000003
Debt to equity: 0.03702010438255801
Current ratio: 4.6283086561301685
Quick ratio: 4.6283086561301685
Effective tax rate (%): 17.42195221208069
Interest coverage ratio: 5.811568373298769
COGS to revenue (%): 94.76187981603874
R&D to revenue (%): 0.9236073462674749
SG&A to revenue (%): 2.5665641275545945
Free cash flow (dilution-adjusted): 10754682.779456193
Buyback yield (%): 0.009587958722570804
Retained earnings: 30062537.76435045
Receivables turnover: 55.405742905742905
Capitalized R&D asset: 22405924.03113615
ROCI (R&D-adjusted, %): 4.861248188677241
Rosenberg metric: 0.26921645869009847
FCF margin (%): 0.8673712423476381
Revenue growth (%): 101.42372515455791
Rule of 40 score: 102.29109639690556
Financial ratios for ETOR — quarterly report dated 2025-12-31
Total revenue: 1215634905.6603773
Gross profit: 34838364.77987421
Operating income: 26267610.06289308
Net income: 21616981.13207547
Capital expenditures: 558176.1006289308
Operating cash flow: 39513836.477987416
Depreciation & amortization: 1141823.8993710692
Net tangible assets: 424961949.6855346
Owner earnings: 22200628.930817608
Return on net tangible assets (%): 5.224145113990967
Capex to operating income (%): 2.1249595958386704
Buffett classification: The Great
Stock price: 35.13
P/E ratio: 36.70869566910952
Shares outstanding: 66806610
Book value: 438550314.4654088
P/B ratio: 5.351532382688819
Market cap (USD): 2346916209.3
Debt to equity: 0.03905305501975491
Current ratio: 4.889634059144727
Quick ratio: 4.889634059144727
Effective tax rate (%): 12.360238152912528
Interest coverage ratio: 12.960589604344454
COGS to revenue (%): 97.13414244542867
R&D to revenue (%): 0.9795590419272585
SG&A to revenue (%): -0.5575935550411191
Free cash flow (dilution-adjusted): 37689937.10691824
Buyback yield (%): 0
Retained earnings: 52908490.56603774
Receivables turnover: 66.49669728558159
Capitalized R&D asset: 23362827.78766779
ROCI (R&D-adjusted, %): 5.547500045996139
Rosenberg metric: -2.6292410852798067
FCF margin (%): 3.1004322869820595
Revenue growth (%): -1.9583580486498628
Rule of 40 score: 1.1420742383321967
Financial ratios for ETOR — annual report dated 2025-12-31
Total revenue: 4342095911.949685
Gross profit: 238315723.27044025
Operating income: 85629559.74842767
Net income: 67828930.81761006
Capital expenditures: 1522327.044025157
Operating cash flow: 100077044.02515723
Depreciation & amortization: 4019811.3207547166
Net tangible assets: 424961949.6855346
Owner earnings: 70326415.09433962
Return on net tangible assets (%): 16.54887341005003
Capex to operating income (%): 1.7778055247482574
Buffett classification: The Great
Stock price: 35.13
P/E ratio: 34.60051899698651
Shares outstanding: 66806610
Book value: 438550314.4654088
P/B ratio: 5.351532382688819
Market cap (USD): 2346916209.3
Debt to equity: 0.03905305501975491
Current ratio: 4.889634059144727
Quick ratio: 4.889634059144727
Effective tax rate (%): 14.87957821792337
Interest coverage ratio: 6.600140582204232
COGS to revenue (%): 94.51150485610918
R&D to revenue (%): 1.0953684729681237
SG&A to revenue (%): 2.341795780882852
Free cash flow (dilution-adjusted): 93277987.42138365
Buyback yield (%): 0.797875596236064
Retained earnings: 52908490.56603774
Receivables turnover: 237.51788970309974
Capitalized R&D asset: 83376668.40195024
ROCI (R&D-adjusted, %): 17.347658670433997
Rosenberg metric: 1.4445177799597693
FCF margin (%): 2.1482249428133895
Revenue growth (%): 25.544810510733257
Rule of 40 score: 27.693035453546646
Financial ratios for FL1.AX — annual report dated 2021-06-30
Operating income: -637681.2030075188
Net income: -639120.3007518797
Capital expenditures: 0
Depreciation & amortization: 539.8496240601503
Net tangible assets: 333403.75939849624
Owner earnings: -638580.4511278196
Return on net tangible assets (%): -191.53366845050033
Buffett classification: The Gruesome
Stock price: 1.3233082706766917
Shares outstanding: 108673604
Book value: 333414.2857142857
P/B ratio: 431.32128747680076
Market cap (USD): 143808678.9774436
Debt to equity: 0.19887876853967046
Current ratio: 0.5610128121451625
Quick ratio: 0.5610128121451625
Interest coverage ratio: -84.8116
Free cash flow (dilution-adjusted): -303716.54135338345
Buyback yield (%): 0
Retained earnings: -20130793.984962404
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -191.25791255206443
Rule of 40 score: 0
Financial ratios for FL1.AX — annual report dated 2022-06-30
Operating income: -666392.4137931034
Net income: -647815.1724137932
Capital expenditures: 1151.0344827586207
Depreciation & amortization: 782.7586206896552
Net tangible assets: 4594159.310344827
Owner earnings: -648183.4482758621
Return on net tangible assets (%): -14.108858759345264
Buffett classification: The Gruesome
Stock price: 0.11034482758620691
Shares outstanding: 108673604
Book value: 4919622.068965517
P/B ratio: 2.437498232272398
Market cap (USD): 11991570.096551726
Debt to equity: 0
Current ratio: 45.62989677363625
Quick ratio: 45.62989677363625
Free cash flow (dilution-adjusted): -906050.3448275862
Buyback yield (%): 3.325646584795329
Retained earnings: -19112345.51724138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.545601764755688
Rule of 40 score: 0
Financial ratios for FL1.AX — annual report dated 2023-06-30
Operating income: -868240.3973509934
Net income: -1632050.3311258277
Capital expenditures: 0
Depreciation & amortization: 859.6026490066225
Net tangible assets: 2521173.509933775
Owner earnings: -1631190.7284768212
Return on net tangible assets (%): -64.69966156830152
Buffett classification: The Gruesome
Stock price: 0.11920529801324503
Shares outstanding: 108673604
Book value: 2521173.509933775
P/B ratio: 5.138269658931034
Market cap (USD): 12954469.350993378
Debt to equity: 0
Current ratio: 14.770205546351027
Quick ratio: 14.770205546351027
Free cash flow (dilution-adjusted): -510676.1589403973
Buyback yield (%): 0
Retained earnings: -20006502.649006624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.437947008803846
Rule of 40 score: 0
Financial ratios for G4M.L — annual report dated 2022-03-31
Total revenue: 194250000
Gross profit: 54118421.05263158
Operating income: 7386842.105263158
Net income: 4898684.2105263155
Capital expenditures: 2207894.736842105
Operating cash flow: -9982894.736842105
Depreciation & amortization: 6760526.315789473
Net tangible assets: 23978947.36842105
Owner earnings: 9451315.789473685
Return on net tangible assets (%): 39.415057067603165
Capex to operating income (%): 29.88956180976131
Buffett classification: The Good
Stock price: 0.05131578947368421
P/E ratio: 0.21974229975825949
Shares outstanding: 20976938
Book value: 50047368.421052635
P/B ratio: 0.021508586128930484
Market cap (USD): 1076448.1342105262
Debt to equity: 0.9907456094226521
Current ratio: 3.0588100160808636
Quick ratio: 0.4447507466115322
Effective tax rate (%): 25.747905863581966
Interest coverage ratio: 5.860125260960333
COGS to revenue (%): 72.13980898191424
SG&A to revenue (%): 24.304680620470094
Free cash flow (dilution-adjusted): -22206578.94736842
Buyback yield (%): 0
Retained earnings: 27789473.684210528
Inventory turnover: 2.3398365409965725
Receivables turnover: 83.31264108352144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.304854722652336
FCF margin (%): -11.431958274063538
Rule of 40 score: -11.431958274063538
Financial ratios for G4M.L — annual report dated 2023-03-31
Total revenue: 187702469.13580245
Gross profit: 48201234.56790123
Operating income: 966666.6666666666
Net income: -795061.7283950617
Capital expenditures: 1182716.049382716
Operating cash flow: 24328395.06172839
Depreciation & amortization: 7507407.407407407
Net tangible assets: 18746913.580246914
Owner earnings: 5529629.629629629
Capex to operating income (%): 122.3499361430396
Buffett classification: The Gruesome
Stock price: 0.010617283950617283
Shares outstanding: 20976938
Book value: 45967901.2345679
P/B ratio: 0.004845078874147284
Market cap (USD): 222718.1071604938
Debt to equity: 0.7412579900091314
Current ratio: 2.308196197475635
Quick ratio: 0.477179528146136
Interest coverage ratio: 0.5206117021276595
COGS to revenue (%): 74.3204046330218
SG&A to revenue (%): 25.457283986345608
Free cash flow (dilution-adjusted): 16182716.049382716
Buyback yield (%): 0
Retained earnings: 25581481.48148148
Inventory turnover: 3.2865827055641192
Receivables turnover: 122.3161705551086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.189336978810663
FCF margin (%): 8.621472122284416
Revenue growth (%): -3.3706722595611596
Rule of 40 score: 5.250799862723257
Financial ratios for G4M.L — annual report dated 2024-03-31
Total revenue: 182764556.9620253
Gross profit: 49920253.16455696
Operating income: 2806329.1139240507
Net income: 824050.6329113924
Capital expenditures: 177215.18987341772
Operating cash flow: 18511392.40506329
Depreciation & amortization: 8407594.93670886
Net tangible assets: 20654430.379746836
Owner earnings: 9054430.379746834
Return on net tangible assets (%): 43.837715266286686
Capex to operating income (%): 6.314839873703202
Buffett classification: The Great
Stock price: 0.017341772151898735
P/E ratio: 0.44145015453149006
Shares outstanding: 20976938
Book value: 48564556.96202532
P/B ratio: 0.007490591945993848
Market cap (USD): 363777.27924050635
Debt to equity: 0.5576030860657873
Current ratio: 2.2384756416972236
Quick ratio: 0.5593897328444213
Effective tax rate (%): -11.472602739726028
Interest coverage ratio: 1.0878312070657508
COGS to revenue (%): 72.68603169326241
SG&A to revenue (%): 26.047900044326237
Free cash flow (dilution-adjusted): 13336708.860759493
Buyback yield (%): 0
Retained earnings: 27478481.012658227
Inventory turnover: 4.0926178684241314
Receivables turnover: 128.34133333333335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6996862692744146
FCF margin (%): 7.2972074468085095
Revenue growth (%): -2.630712422970079
Rule of 40 score: 4.666495023838431
Financial ratios for G4M.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 20797333.333333332
Buffett classification: The Gruesome
Stock price: 0.023066666666666666
Shares outstanding: 20976938
Book value: 49717333.33333333
P/B ratio: 0.009732381125295002
Market cap (USD): 483868.0365333333
Debt to equity: 0.7952960738039048
Current ratio: 2.1932155971323657
Quick ratio: 0.4418167511802763
Buyback yield (%): 0
Retained earnings: 27448000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for G4M.L — annual report dated 2025-03-31
Total revenue: 190545454.54545453
Gross profit: 51510389.61038961
Operating income: 3529870.1298701297
Net income: 1080519.4805194805
Capital expenditures: 432467.53246753244
Operating cash flow: 10720779.22077922
Depreciation & amortization: 8833766.233766234
Net tangible assets: 22983116.883116882
Owner earnings: 9481818.181818182
Return on net tangible assets (%): 41.255580041815
Capex to operating income (%): 12.251655629139073
Buffett classification: The Great
Stock price: 0.017532467532467535
P/E ratio: 0.3403709891826924
Shares outstanding: 20976938
Book value: 51042857.142857134
P/B ratio: 0.007205268376459815
Market cap (USD): 367777.4844155845
Debt to equity: 0.5040073276849096
Current ratio: 1.9804956402019276
Quick ratio: 0.41128958237723723
Effective tax rate (%): 46.7349551856594
Interest coverage ratio: 1.6861042183622827
COGS to revenue (%): 72.96687568157034
SG&A to revenue (%): 25.44642857142857
Free cash flow (dilution-adjusted): 5412987.012987013
Buyback yield (%): 0
Retained earnings: 29394805.194805194
Inventory turnover: 3.130962477700114
Receivables turnover: 133.38181818181818
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.561627282491944
FCF margin (%): 2.840785169029444
Revenue growth (%): 4.257333978078653
Rule of 40 score: 7.098119147108097
Financial ratios for G4M.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 22983116.883116882
Buffett classification: The Gruesome
Stock price: 0.017532467532467535
Shares outstanding: 20976938
Book value: 51042857.142857134
P/B ratio: 0.007205268376459815
Market cap (USD): 367777.4844155845
Debt to equity: 0.5040073276849096
Current ratio: 1.9804956402019276
Quick ratio: 0.41128958237723723
Buyback yield (%): 0
Retained earnings: 29394805.194805194
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for G4M.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 27278378.37837838
Buffett classification: The Gruesome
Stock price: 0.040135135135135135
Shares outstanding: 20976938
Book value: 55870270.27027027
P/B ratio: 0.015069056177438079
Market cap (USD): 841912.2413513514
Debt to equity: 0.651968846749226
Current ratio: 2.192811059907834
Quick ratio: 0.3478709677419355
Buyback yield (%): 0
Retained earnings: 33391891.891891893
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.63
Shares outstanding: 23986608
Market cap (USD): 782683019.0400001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAM — annual report dated 2022-12-31
Total revenue: -171809793
Net income: -177274676
Capital expenditures: 0
Net tangible assets: 1041159645
Owner earnings: -177274676
Return on net tangible assets (%): -17.0266564643888
Buffett classification: The Gruesome
Stock price: 27.79
Shares outstanding: 23986608
Book value: 1041159645
P/B ratio: 0.6402359518265808
Market cap (USD): 666587836.3199999
Debt to equity: 0.003378333012513177
Buyback yield (%): 0
Retained earnings: 657574137
Receivables turnover: -44.86666194871077
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAM — annual report dated 2023-12-31
Total revenue: 279560446
Net income: 273403798
Capital expenditures: 0
Net tangible assets: 1423070763
Owner earnings: 273403798
Return on net tangible assets (%): 19.212241942462
Buffett classification: The Gruesome
Stock price: 35.24
P/E ratio: 3.09172027639499
Shares outstanding: 23986608
Book value: 1423070763
P/B ratio: 0.5939887796851604
Market cap (USD): 845288065.9200001
Debt to equity: 0.002096597778251172
COGS to revenue (%): 0
SG&A to revenue (%): 2.006073133822372
Buyback yield (%): 0
Retained earnings: 859853752
Receivables turnover: 48.01299179060901
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAM — annual report dated 2024-12-31
Total revenue: 251672733
Net income: 245455190
Capital expenditures: 0
Depreciation & amortization: 157036
Net tangible assets: 1546027662
Owner earnings: 245612226
Return on net tangible assets (%): 15.886664387509516
Buffett classification: The Gruesome
Stock price: 45.66
P/E ratio: 4.462030406772006
Shares outstanding: 23986608
Book value: 1546027662
P/B ratio: 0.7084145699328374
Market cap (USD): 1095228521.28
Debt to equity: 0.0015528700158535715
COGS to revenue (%): 0
SG&A to revenue (%): 2.178272129305323
Buyback yield (%): 0
Retained earnings: 992859908
Receivables turnover: 21.527618256269026
Capitalized R&D asset: 0
Revenue growth (%): -9.97555748641208
Rule of 40 score: -9.97555748641208
Financial ratios for GAM — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1546027662
Buffett classification: The Gruesome
Stock price: 45.66
Shares outstanding: 23986608
Book value: 1546027662
P/B ratio: 0.7084145699328374
Market cap (USD): 1095228521.28
Debt to equity: 0.0015528700158535715
Buyback yield (%): 0
Retained earnings: 992859908
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAM — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1675122258
Buffett classification: The Gruesome
Stock price: 50.4
Shares outstanding: 23986608
Book value: 1675122258
P/B ratio: 0.7216936181382887
Market cap (USD): 1208925043.2
Debt to equity: 0.0012553370298539726
Buyback yield (%): 0
Retained earnings: 1131729353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCV — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 20147486
Market cap (USD): 83813541.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCV — annual report dated 2022-12-31
Total revenue: -31034481
Net income: -31578273
Capital expenditures: 0
Operating cash flow: 26960333
Net tangible assets: 80247278
Owner earnings: -31578273
Return on net tangible assets (%): -39.351207650931165
Buffett classification: The Gruesome
Stock price: 3.16
Shares outstanding: 20147486
Book value: 80247278
P/B ratio: 0.7933733996559983
Market cap (USD): 63666055.760000005
Debt to equity: 0
Free cash flow (dilution-adjusted): 26960333
Buyback yield (%): 53.026686822353255
Retained earnings: -6970501
Receivables turnover: -33.10927363215926
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCV — annual report dated 2023-09-30
Total revenue: 871288
Net income: 456829
Capital expenditures: 0
Operating cash flow: 6035506
Net tangible assets: 74485607
Owner earnings: 456829
Return on net tangible assets (%): 0.613311777132997
Buffett classification: The Gruesome
Stock price: 2.69
P/E ratio: 118.63681451921833
Shares outstanding: 20147486
Book value: 74485607
P/B ratio: 0.7276135554617955
Market cap (USD): 54196737.339999996
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 37.21306846874971
Free cash flow (dilution-adjusted): 6035506
Buyback yield (%): 0
Retained earnings: -11510323
Receivables turnover: 0.8189274187029695
Capitalized R&D asset: 0
FCF margin (%): 692.7107913801177
Rule of 40 score: 692.7107913801177
Financial ratios for GCV — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 73913640
Buffett classification: The Gruesome
Stock price: 2.99
Shares outstanding: 20147486
Book value: 73913640
P/B ratio: 0.8150184883331413
Market cap (USD): 60240983.14
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -4847426
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCV — annual report dated 2024-09-30
Total revenue: 8064641
Net income: 7563639
Capital expenditures: 0
Operating cash flow: 16841420
Net tangible assets: 73913640
Owner earnings: 7563639
Return on net tangible assets (%): 10.233076060115561
Buffett classification: The Gruesome
Stock price: 2.99
P/E ratio: 7.964550283269734
Shares outstanding: 20147486
Book value: 73913640
P/B ratio: 0.8150184883331413
Market cap (USD): 60240983.14
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 4.637850587521503
Free cash flow (dilution-adjusted): 16841420
Buyback yield (%): 14.275995429911239
Retained earnings: -4847426
Receivables turnover: 6.27937656602087
Capitalized R&D asset: 0
FCF margin (%): 208.83037447048173
Revenue growth (%): 825.5999164455382
Rule of 40 score: 1034.4302909160199
Financial ratios for GCV — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 71882025
Buffett classification: The Gruesome
Stock price: 3.24
Shares outstanding: 20147486
Book value: 71882025
P/B ratio: 0.9081248704387502
Market cap (USD): 65277854.64
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -7717645
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCV — annual report dated 2025-09-30
Total revenue: 21874316
Net income: 21437685
Capital expenditures: 0
Operating cash flow: 9120744
Net tangible assets: 87066457
Owner earnings: 21437685
Return on net tangible assets (%): 24.622208986866205
Buffett classification: The Gruesome
Stock price: 3.8
P/E ratio: 3.5713019759363007
Shares outstanding: 20147486
Book value: 87066457
P/B ratio: 0.8793334360671181
Market cap (USD): 76560446.8
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.302116143883082
Free cash flow (dilution-adjusted): 9120744
Buyback yield (%): 0
Retained earnings: 7168944
Receivables turnover: 65.23531973016337
Capitalized R&D asset: 0
FCF margin (%): 41.69613349281413
Revenue growth (%): 171.2373185613594
Rule of 40 score: 212.93345205417353
Financial ratios for GCV — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 87066457
Buffett classification: The Gruesome
Stock price: 3.8
Shares outstanding: 20147486
Book value: 87066457
P/B ratio: 0.8793334360671181
Market cap (USD): 76560446.8
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 7168944
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GME.DE — annual report dated 2021-12-31
Total revenue: 27998492.045454547
Gross profit: 18546335.227272727
Operating income: 983552.2727272727
Net income: 378007.95454545453
Capital expenditures: 1443181.8181818181
Operating cash flow: 1042045.4545454546
Depreciation & amortization: 1948863.6363636365
Net tangible assets: 15715950
Owner earnings: 883689.7727272727
Return on net tangible assets (%): 5.622884857277306
Capex to operating income (%): 146.73158287561552
Buffett classification: The Gruesome
Stock price: 8.659090909090908
P/E ratio: 123.97232171040172
Shares outstanding: 5411945
Book value: 20553604.545454547
P/B ratio: 2.280014858044143
Market cap (USD): 46862523.74999999
Debt to equity: 0.4610004814461874
Current ratio: 8.778507567541949
Quick ratio: 4.792680388324974
Effective tax rate (%): -8.12935983201035
Interest coverage ratio: 6.045695845324243
COGS to revenue (%): 33.75952105862194
SG&A to revenue (%): 19.7413229194608
Free cash flow (dilution-adjusted): -401136.36363636365
Buyback yield (%): 0
Retained earnings: -1075172.7272727273
Inventory turnover: 0.9696363026584657
Receivables turnover: 7.7557783503288675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8464830431663173
FCF margin (%): -1.4327070293111972
Rule of 40 score: -1.4327070293111972
Financial ratios for GME.DE — annual report dated 2022-12-31
Total revenue: 29191638.297872342
Gross profit: 19022769.14893617
Operating income: 3247219.1489361706
Net income: 1152188.2978723405
Capital expenditures: 2278723.4042553194
Operating cash flow: 2962765.9574468085
Depreciation & amortization: 1570472.340425532
Net tangible assets: 19275327.659574468
Owner earnings: 443937.23404255323
Return on net tangible assets (%): 2.303137160016266
Capex to operating income (%): 70.17461094370108
Buffett classification: The Good
Stock price: 4.904255319148937
P/E ratio: 23.03578338905524
Shares outstanding: 5411945
Book value: 23646715.957446806
P/B ratio: 1.1224205551821262
Market cap (USD): 26541560.05319149
Debt to equity: 0.41815279734089306
Current ratio: 10.780798874340062
Quick ratio: 7.237117757615096
Effective tax rate (%): 36.387333578954106
Interest coverage ratio: 17.007778458795343
COGS to revenue (%): 34.83486964716652
SG&A to revenue (%): 18.097575303916088
Free cash flow (dilution-adjusted): 48936.17021276596
Buyback yield (%): 0
Retained earnings: -706806.3829787235
Inventory turnover: 1.2346937167486374
Receivables turnover: 7.267781142376006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.433002110028362
FCF margin (%): 0.16763762867099075
Revenue growth (%): 4.261466119249442
Rule of 40 score: 4.429103747920433
Financial ratios for GME.DE — annual report dated 2023-12-31
Total revenue: 24778748.099999998
Gross profit: 19819746.555555552
Operating income: 3538141.5555555555
Net income: 1850462.8666666667
Capital expenditures: 842222.2222222222
Operating cash flow: 1635555.5555555555
Depreciation & amortization: 1912222.2222222222
Net tangible assets: 19669279.23333333
Owner earnings: 2920462.866666667
Return on net tangible assets (%): 14.847838764307072
Capex to operating income (%): 23.804084969403586
Buffett classification: The Great
Stock price: 5.666666666666666
P/E ratio: 16.57298229851897
Shares outstanding: 5411945
Book value: 25123409.33333333
P/B ratio: 1.22068179228541
Market cap (USD): 30667688.33333333
Debt to equity: 0.3197968460437721
Current ratio: 2.112041031506913
Quick ratio: 1.168127950825053
Effective tax rate (%): 27.77436387236023
Interest coverage ratio: 20.827660003787052
COGS to revenue (%): 20.013123844801683
SG&A to revenue (%): 20.54179645984617
Free cash flow (dilution-adjusted): -190000
Buyback yield (%): 0.8441747746845899
Retained earnings: -406565.4111111111
Inventory turnover: 0.4752528204775554
Receivables turnover: 12.312813590733498
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.356630084246058
FCF margin (%): -0.7667861153970084
Revenue growth (%): -15.116966553377656
Rule of 40 score: -15.883752668774665
Financial ratios for GME.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 20218050.489583332
Buffett classification: The Gruesome
Stock price: 3.5208333333333335
Shares outstanding: 5411945
Book value: 21692193.260416664
P/B ratio: 0.8784061678510358
Market cap (USD): 19054556.354166668
Debt to equity: 0.15741070035385377
Current ratio: 5.211505394809842
Quick ratio: 3.5523127897505464
Buyback yield (%): 0
Retained earnings: -210342.82291666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GME.DE — annual report dated 2024-12-31
Total revenue: 15015226.03125
Gross profit: 7056348.156250001
Operating income: -4424036.21875
Net income: 734554.4270833334
Capital expenditures: 201041.6666666667
Operating cash flow: 1944791.6666666667
Depreciation & amortization: 1935715.2291666667
Net tangible assets: 20218050.489583332
Owner earnings: 2469227.9895833335
Return on net tangible assets (%): 12.212987552165428
Buffett classification: The Gruesome
Stock price: 3.5208333333333335
P/E ratio: 25.94029203503116
Shares outstanding: 5411945
Book value: 21692193.260416664
P/B ratio: 0.8784061678510358
Market cap (USD): 19054556.354166668
Debt to equity: 0.15741070035385377
Current ratio: 5.211505394809842
Quick ratio: 3.5523127897505464
Interest coverage ratio: -39.175348707042545
COGS to revenue (%): 53.00538172676068
SG&A to revenue (%): 22.886490860552517
Free cash flow (dilution-adjusted): 1277083.3333333335
Buyback yield (%): 0
Retained earnings: -210342.82291666666
Inventory turnover: 1.2952756064493518
Receivables turnover: 12.079197926314901
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.999087877503946
FCF margin (%): 8.505255469850677
Revenue growth (%): -39.40280610363039
Rule of 40 score: -30.897550633779712
Financial ratios for GME.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.623529411764706
Shares outstanding: 5411945
Market cap (USD): 19610341.88235294
Buyback yield (%): 0
Retained earnings: -458956.4705882353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMG.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1417322.8346456692
Buffett classification: The Gruesome
Stock price: 3.1023622047244093
Shares outstanding: 578000000
Market cap (USD): 1793165354.3307085
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMG.TO — annual report dated 2022-12-31
Total revenue: 705000000
Gross profit: 108749999.99999999
Operating income: 40588235.294117644
Net income: -38823529.4117647
Capital expenditures: 0
Operating cash flow: 300514705.88235295
Depreciation & amortization: 177941176.47058824
Net tangible assets: 1566764705.8823528
Owner earnings: 139117647.05882353
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.551470588235294
Shares outstanding: 578000000
Book value: 1622647058.8235295
P/B ratio: 0.9088544498821822
Market cap (USD): 1474750000
Debt to equity: 0.4497462388979517
Current ratio: 2.3542246982358406
Quick ratio: 2.044877746827608
Effective tax rate (%): 187.29016786570742
COGS to revenue (%): 84.57446808510637
SG&A to revenue (%): 5.329578639966625
Free cash flow (dilution-adjusted): -250735294.11764705
Buyback yield (%): 0
Retained earnings: -464999999.99999994
Inventory turnover: 4.056528264132067
Receivables turnover: 11.551807228915663
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4607425441265975
FCF margin (%): -35.565289945765535
Rule of 40 score: -35.565289945765535
Financial ratios for IMG.TO — annual report dated 2023-12-31
Total revenue: 747803030.3030303
Gross profit: 94015151.51515152
Operating income: 21969696.96969697
Net income: 78636363.63636363
Capital expenditures: 148863636.36363634
Operating cash flow: 120757575.75757575
Depreciation & amortization: 167954545.45454544
Net tangible assets: 1671212121.2121212
Owner earnings: 97727272.72727272
Return on net tangible assets (%): 5.84768812330009
Capex to operating income (%): 677.5862068965517
Buffett classification: The Gruesome
Stock price: 2.5303030303030303
P/E ratio: 18.598458574181123
Shares outstanding: 578000000
Book value: 1715227272.7272725
P/B ratio: 0.8526655183074954
Market cap (USD): 1462515151.5151515
Debt to equity: 0.4205202950399718
Current ratio: 1.194831959416614
Quick ratio: 0.7726696258719087
Effective tax rate (%): 23.946957878315136
COGS to revenue (%): 87.42781886333705
SG&A to revenue (%): 4.751291662445548
Free cash flow (dilution-adjusted): -572121212.1212121
Buyback yield (%): 0
Retained earnings: -407803030.3030303
Inventory turnover: 3.240705970709726
Receivables turnover: 14.558997050147493
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7422384889048144
FCF margin (%): -76.5069395198055
Revenue growth (%): 6.07135181603266
Rule of 40 score: -70.43558770377284
Financial ratios for IMG.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.2518518518518515
Shares outstanding: 578000000
Market cap (USD): 3035570370.3703704
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMG.TO — annual report dated 2024-12-31
Total revenue: 1141958041.958042
Gross profit: 384545454.54545456
Operating income: 344335664.33566433
Net income: 592867132.8671329
Capital expenditures: 24825174.825174827
Operating cash flow: 339860139.86013985
Depreciation & amortization: 192307692.30769232
Net tangible assets: 2333356643.3566437
Owner earnings: 760349650.3496504
Return on net tangible assets (%): 32.586088051068415
Capex to operating income (%): 7.209585702680749
Buffett classification: The Great
Stock price: 5.195804195804196
P/E ratio: 5.0655107336636
Shares outstanding: 578000000
Book value: 2378111888.1118884
P/B ratio: 1.262840003528685
Market cap (USD): 3003174825.174825
Debt to equity: 0.33907724880171725
Current ratio: 1.2137667998547041
Quick ratio: 0.719941881583727
Effective tax rate (%): 13.241915677445762
Interest coverage ratio: 37.02255639097744
COGS to revenue (%): 66.32578077158604
SG&A to revenue (%): 2.663808940600123
Free cash flow (dilution-adjusted): -55104895.10489511
Buyback yield (%): 0
Retained earnings: 181398601.3986014
Inventory turnover: 3.9834497977197496
Receivables turnover: 47.060518731988466
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.207720054728636
FCF margin (%): -4.825474586650337
Revenue growth (%): 52.70839989713457
Rule of 40 score: 47.88292531048423
Financial ratios for IMG.TO — quarterly report dated 2024-12-31
Capital expenditures: 24825174.825174827
Buffett classification: The Gruesome
Stock price: 5.195804195804196
Shares outstanding: 578000000
Market cap (USD): 3003174825.174825
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMG.TO — quarterly report dated 2025-03-31
Total revenue: 333636363.6363636
Gross profit: 98741258.74125874
Operating income: 78461538.46153846
Net income: 32517482.51748252
Capital expenditures: 0
Operating cash flow: 51958041.95804196
Depreciation & amortization: 55734265.73426574
Net tangible assets: 2372307692.3076925
Owner earnings: 88251748.25174826
Return on net tangible assets (%): 3.720080179224148
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.27972027972028
P/E ratio: 27.905591397849463
Shares outstanding: 578000000
Book value: 2421818181.818182
P/B ratio: 1.4987410487410489
Market cap (USD): 3629678321.678322
Debt to equity: 0.33165858165858164
Current ratio: 1.4125337206889397
Quick ratio: 0.8275575845611123
Effective tax rate (%): 45.7409568261377
Interest coverage ratio: 6.0978260869565215
COGS to revenue (%): 70.40452735275625
SG&A to revenue (%): 3.4374345001048003
Free cash flow (dilution-adjusted): 4405594.405594406
Buyback yield (%): 0
Retained earnings: 209160839.16083917
Inventory turnover: 1.191557289819085
Receivables turnover: 7.7577235772357716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2862498981172057
FCF margin (%): 1.3204778872353806
Rule of 40 score: 1.3204778872353806
Financial ratios for IMG.TO — quarterly report dated 2025-06-30
Total revenue: 424014598.54014593
Gross profit: 145109489.0510949
Operating income: 129635036.49635035
Net income: 62700729.927007295
Capital expenditures: 58540145.98540145
Operating cash flow: 62627737.22627737
Depreciation & amortization: 69343065.69343065
Net tangible assets: 2506204379.5620437
Owner earnings: 73503649.6350365
Return on net tangible assets (%): 2.9328673365370617
Capex to operating income (%): 45.15765765765766
Buffett classification: The Good
Stock price: 7.321167883211678
P/E ratio: 44.44144589422221
Shares outstanding: 578000000
Book value: 2506642335.766423
P/B ratio: 1.6881686613668792
Market cap (USD): 4231635036.49635
Debt to equity: 0.34699047785445963
Current ratio: 1.4740180531837033
Quick ratio: 0.7577457916565015
Effective tax rate (%): 47.87621359223301
Interest coverage ratio: 9.652173913043478
COGS to revenue (%): 65.77724221036323
SG&A to revenue (%): 2.151833362024445
Free cash flow (dilution-adjusted): 2992700.729927007
Buyback yield (%): 0
Retained earnings: 238613138.68613136
Inventory turnover: 1.3014305177111716
Receivables turnover: 9.476345840130506
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6118850541986123
FCF margin (%): 0.705801342744018
Revenue growth (%): 27.088844249090066
Rule of 40 score: 27.794645591834083
Financial ratios for IMG.TO — quarterly report dated 2025-09-30
Total revenue: 508417266.1870504
Gross profit: 196115107.91366908
Operating income: 180791366.90647483
Net income: 111654676.25899282
Capital expenditures: 47841726.61870504
Operating cash flow: 202014388.48920864
Depreciation & amortization: 79064748.20143886
Net tangible assets: 2565395683.4532375
Owner earnings: 142877697.84172666
Return on net tangible assets (%): 5.569421464426934
Capex to operating income (%): 26.46239554317549
Buffett classification: The Good
Stock price: 12.935251798561152
P/E ratio: 36.14091525683075
Shares outstanding: 578000000
Book value: 2577050359.7122307
P/B ratio: 2.901214371458083
Market cap (USD): 7476575539.568346
Debt to equity: 0.30468161134530025
Current ratio: 1.683695917868492
Quick ratio: 0.9486678073820584
Effective tax rate (%): 22.24448897795591
Interest coverage ratio: 8.75609756097561
COGS to revenue (%): 61.426347813782364
SG&A to revenue (%): 2.0659402858355738
Free cash flow (dilution-adjusted): 152949640.2877698
Buyback yield (%): 0
Retained earnings: 335467625.8992806
Inventory turnover: 1.4436315264383106
Receivables turnover: 24.037414965986393
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.058882737795671
FCF margin (%): 30.08348662798925
Revenue growth (%): 19.905604179077145
Rule of 40 score: 49.98909080706639
Financial ratios for IMG.TO — quarterly report dated 2025-12-31
Total revenue: 794233576.6423357
Gross profit: 433284671.5328467
Operating income: 413722627.73722625
Net income: 324598540.14598536
Capital expenditures: 65693430.6569343
Operating cash flow: 512189781.0218978
Depreciation & amortization: 99489051.0948905
Net tangible assets: 3059416058.3941603
Owner earnings: 358394160.5839415
Return on net tangible assets (%): 11.714462947941021
Capex to operating income (%): 15.878616796047988
Buffett classification: The Great
Stock price: 16.532846715328464
P/E ratio: 17.980242930737965
Shares outstanding: 578000000
Book value: 3099197080.2919707
P/B ratio: 3.0833745495654625
Market cap (USD): 9555985401.459852
Debt to equity: 0.17942014649426502
Current ratio: 1.747631019145233
Quick ratio: 1.0185650744536838
Effective tax rate (%): 14.431402732345585
Interest coverage ratio: 13.960591133004925
COGS to revenue (%): 45.446190607480936
SG&A to revenue (%): 1.0844591489752782
Free cash flow (dilution-adjusted): 445036496.3503649
Buyback yield (%): 0
Retained earnings: 636934306.569343
Inventory turnover: 1.3116710875331565
Receivables turnover: 17.866995073891623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.623383438917418
FCF margin (%): 56.033452807646356
Revenue growth (%): 56.21687725100417
Rule of 40 score: 112.25033005865052
Financial ratios for IMG.TO — annual report dated 2025-12-31
Total revenue: 2082335766.4233575
Gross profit: 880437956.2043794
Operating income: 810510948.9051094
Net income: 534525547.44525546
Capital expenditures: 0
Operating cash flow: 834014598.5401459
Depreciation & amortization: 307226277.3722628
Net tangible assets: 3059416058.3941603
Owner earnings: 841751824.8175182
Return on net tangible assets (%): 27.51347998282197
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.532846715328464
P/E ratio: 17.877509217533795
Shares outstanding: 578000000
Book value: 3099197080.2919707
P/B ratio: 3.0833745495654625
Market cap (USD): 9555985401.459852
Debt to equity: 0.17942014649426502
Current ratio: 1.747631019145233
Quick ratio: 1.0185650744536838
Effective tax rate (%): 24.489585481542587
Interest coverage ratio: 10.575238095238095
COGS to revenue (%): 57.7187324733595
SG&A to revenue (%): 1.9384464385866516
Free cash flow (dilution-adjusted): 607810218.9781021
Buyback yield (%): 0.3819213700283386
Retained earnings: 636934306.569343
Inventory turnover: 4.36763925729443
Receivables turnover: 46.8440065681445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.81193537504217
FCF margin (%): 29.1888670779585
Revenue growth (%): 82.34783502666266
Rule of 40 score: 111.53670210462116
Financial ratios for INDRAMEDCO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7163391797441646
Shares outstanding: 91673000
Market cap (USD): 65668961.6246868
Buyback yield (%): 0
Retained earnings: 25824871.42291969
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDRAMEDCO.NS — annual report dated 2023-03-31
Total revenue: 129713763.70280147
Gross profit: 41979293.54445798
Operating income: 13678440.925700366
Net income: 10493300.852618758
Capital expenditures: 5429963.459196103
Operating cash flow: 17596833.130328868
Depreciation & amortization: 4783191.230207065
Net tangible assets: 46101096.22411694
Owner earnings: 9846528.623629719
Return on net tangible assets (%): 21.35855636872836
Capex to operating income (%): 39.697239536954584
Buffett classification: The Good
Stock price: 0.9036540803897686
P/E ratio: 7.8946255020313405
Shares outstanding: 91673000
Book value: 46218026.79658952
P/B ratio: 1.792388949795757
Market cap (USD): 82840680.51157126
Debt to equity: 0.006535775464488075
Current ratio: 1.720897940291599
Quick ratio: 1.6557124122502507
Effective tax rate (%): 26.480628093531315
Interest coverage ratio: 244.13043478260872
COGS to revenue (%): 67.63697826189023
SG&A to revenue (%): 9.104652800600967
Free cash flow (dilution-adjusted): 12166869.671132766
Buyback yield (%): 0
Retained earnings: 31554202.192448236
Inventory turnover: 85.24260355029587
Receivables turnover: 15.60594958968347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.39185918074781
FCF margin (%): 9.379783088407907
Rule of 40 score: 9.379783088407907
Financial ratios for INDRAMEDCO.NS — annual report dated 2024-03-31
Total revenue: 144389015.46948075
Gross profit: 50737498.50101931
Operating income: 19676220.170284208
Net income: 14865091.73761842
Capital expenditures: 8321141.623695887
Operating cash flow: 24001678.858376306
Depreciation & amortization: 4806331.694447775
Net tangible assets: 57166326.897709556
Owner earnings: 11350281.808370307
Return on net tangible assets (%): 19.854838371336868
Capex to operating income (%): 42.29034617259873
Buffett classification: The Good
Stock price: 2.0170345489443378
P/E ratio: 12.439049248343142
Shares outstanding: 91673000
Book value: 57292241.27593237
P/B ratio: 3.2274458825029635
Market cap (USD): 184907608.20537427
Debt to equity: 0.0710607836570663
Current ratio: 1.8618063112078345
Quick ratio: 1.8162858179180266
Effective tax rate (%): 25.374751670579737
Interest coverage ratio: 154.7924528301887
COGS to revenue (%): 64.86055512183778
SG&A to revenue (%): 9.631579821603573
Free cash flow (dilution-adjusted): 15680537.234680418
Buyback yield (%): 0
Retained earnings: 42633409.28168845
Inventory turnover: 103.71314741035856
Receivables turnover: 20.617465753424657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.41450647162167
FCF margin (%): 10.859923924056941
Revenue growth (%): 11.313565613825714
Rule of 40 score: 22.173489537882656
Financial ratios for INDRAMEDCO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 62541806.02006689
Buffett classification: The Gruesome
Stock price: 5.057931199235547
Shares outstanding: 91673000
Book value: 62640946.01051123
P/B ratio: 7.4021188433156
Market cap (USD): 463675726.8275203
Debt to equity: 0.06242968556337357
Current ratio: 2.0654591987400335
Quick ratio: 2.0267742888079536
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDRAMEDCO.NS — quarterly report dated 2024-12-31
Total revenue: 37875043.71138827
Gross profit: 12883785.98904301
Operating income: 4776780.510549014
Net income: 3824455.0646928544
Capital expenditures: 0
Depreciation & amortization: 1306679.10012822
Owner earnings: 5131134.164821074
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.038116330574659
P/E ratio: 36.18373265010668
Shares outstanding: 91673000
Market cap (USD): 553532238.3727707
Effective tax rate (%): 26.3193352795868
Interest coverage ratio: 25.936708860759495
COGS to revenue (%): 65.98344258763427
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INDRAMEDCO.NS — annual report dated 2025-03-31
Total revenue: 158564414.30909514
Gross profit: 57706336.21697451
Operating income: 23373860.18237082
Net income: 18820434.88426467
Capital expenditures: 4247135.842880524
Operating cash flow: 18324760.34603694
Depreciation & amortization: 5182370.820668693
Net tangible assets: 69685527.23871872
Owner earnings: 19755669.86205284
Return on net tangible assets (%): 28.34974584374843
Capex to operating income (%): 18.170451135340603
Buffett classification: The Great
Stock price: 4.463648033609523
P/E ratio: 21.74211216166982
Shares outstanding: 91673000
Book value: 69754500.8183306
P/B ratio: 5.866230872338982
Market cap (USD): 409196006.18508583
Debt to equity: 0.054903801032379164
Current ratio: 2.412455934195065
Quick ratio: 2.373342286385765
Effective tax rate (%): 25.57784763313609
Interest coverage ratio: 31.88835725677831
COGS to revenue (%): 63.60700698929488
SG&A to revenue (%): 7.254711138635761
Free cash flow (dilution-adjusted): 14077624.503156416
Buyback yield (%): 0
Inventory turnover: 123.42489270386267
Receivables turnover: 17.976938369781312
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.71274018813808
FCF margin (%): 8.878173936123153
Revenue growth (%): 9.817505018316728
Rule of 40 score: 18.69567895443988